<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The leptin receptor deficient db/db mouse has served as a <z:e sem="disease" ids="C1519106" disease_type="Experimental Model of Disease" abbrv="">rodent model</z:e> for <z:hpo ids='HP_0001513'>obesity</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> for more than 40 years </plain></SENT>
<SENT sid="1" pm="."><plain>Diabetic features in db/db mice follow an age-dependent progression, with early <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> followed by an insulin secretory defect resulting in profound <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Diabetic db/db mice have been utilized to assess the cardiac consequences of <z:mp ids='MP_0002055'>diabetes</z:mp>, specifically evidence for a distinct diabetic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The db/db model is characterized by a contractile function deficit in the heart which becomes manifest 8-10 weeks after birth </plain></SENT>
<SENT sid="4" pm="."><plain>Metabolic changes include an increased reliance on fatty acids and a decreased reliance on <z:chebi fb="105" ids="17234">glucose</z:chebi> as a fuel source for oxidative metabolism within the heart </plain></SENT>
<SENT sid="5" pm="."><plain>As a mouse model for type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, both drug treatment and transgenic manipulation have proven beneficial towards improving metabolism and contractile function </plain></SENT>
<SENT sid="6" pm="."><plain>The db/db mouse model has provided a useful resource to understand and treat the type 2 diabetic condition </plain></SENT>
</text></document>